comparemela.com

Latest Breaking News On - Josephine kraus - Page 1 : comparemela.com

CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease

PRINCETON, N.J., July 11, 2023 CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its.

United statesUnited kingdomChris cramerRalf kohnenKathleen blochChristian steinerJosephine krausCytosorbent cytosorbCytosorbents europe gmbHumedics gmbEuropean unionNational heartCytosorbents corporation contactUs department of healthHealth canadaUs air

CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesEfthymiosn deliargyrisJosephine krausEric kimMarcus schultMichaelj mackKathleen blochMaterial commandEuropean company contactCardiovascular serviceEuropean unionBaylor plano research centerUs armyBlood instituteNational heartCytosorbents corporation

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

New jerseyUnited statesState of new jerseyJosephine krausAstra zenecaPhillip chanMarcus schultKathleen blochJanssen bayerUs centers of diseaseDepartment of defenseEuropean company contactMaterial commandUs national institutes of healthTurkish ministry of healthEuropean association for cardio

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

New jerseyUnited statesState of new jerseyJosephine krausAstra zenecaPhillip chanMarcus schultKathleen blochJanssen bayerUs centers of diseaseDepartment of defenseEuropean company contactMaterial commandUs national institutes of healthTurkish ministry of healthEuropean association for cardio

Enhanced Lung Rest with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U S Hospitals

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

France generalUnited statesJw awori hayangaJosephine krausJoerg scheierMarcus schultKathleen blochCytosorbents europe gmbEric kimRobert bartlettPhillip chanMaterial commandVirginia university school of medicineEuropean unionUs armyBlood institute

vimarsana © 2020. All Rights Reserved.